1Callis TE, Jensen BC ,Weck KE, et M. Evolving molecular diagnostics for familial cardiomyopathies:at the heart of it all[J]. Expert Rev Mol Diagn, 2010, 10(3):329-351.
2Subasic K. Hypertrophic cardiomyopathy [J]. Nurs Clin North Am, 2013, 48(4):571-584.
3Marian AJ. Hypertrophic cardiomyopathy: from genetics to treatment[J]. Eur J Clin Invest, 2010, 40(4):360-369.
4Maron B J, Maron MS, Semsarian C, et al. Genetics of hy- pertrophic cardiomyopathy after 20 years: clinical perspec- tives[J].J Am Coll Cardiol, 2012, 60(8) :705-715.
5Ackerman M J, Priori SG, Willems S, et al. HRS/EHRA ex- pert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies [J]. Heart Rhythm Association (EHRA).Europace, 2011, 13 (8): 1077-1079.
6Villard E, Perret C, Gary F, et al. A genome-wide associa- tion study identifies two loci associated with heart failure due to dilated cardiomyopathy [J]. Eur Heart J, 2011, 32 (9):1065-1076.
7Kimura A. Molecular basis of hereditary cardiomyopathy: abnormalities in cal-cium sensitivity, stretch response, stress response and beyond[J].J Hum Genet, 2010, 55: 81-90.
8Arimura T, Ishikawa T, Nunoda S, et al. Dilated cardiomy- opathy-associated BAG3 mutations impair Z-disc assem- bly and enhance sensitivity to apoptosisin cardiomyoeytes [J]. Hum Murat, 2011, 32:1481-491.
9Norton N, Li D, Rieder M J, et al. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy [J].Am J Hum Genet, 2011, 88(3 ):273-282.
10Barahona-Dussault C, Benito B, Campuzano 0, et al. Role of genetic testing in arrhythmogenic right ventricular car- diomyopathy/dysplasia[J]. Clin Genet, 2010, 77:37-48.
